{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T04:06:27Z","timestamp":1748837187404},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1756-0500-7-266","type":"journal-article","created":{"date-parts":[[2014,4,23]],"date-time":"2014-04-23T21:51:15Z","timestamp":1398289875000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["High rates of early treatment discontinuation in hepatitis C-infected US veterans"],"prefix":"10.1186","volume":"7","author":[{"given":"Joanne","family":"LaFleur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Hoop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott L","family":"DuVall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prashant","family":"Pandya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eli","family":"Korner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristin","family":"Knippenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Candace","family":"Hayden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard E","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,4,24]]},"reference":[{"issue":"4","key":"2807_CR1","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1002\/hep.22759","volume":"49","author":"MG Ghany","year":"2009","unstructured":"Ghany MG, Strader DB, Thomas DL, Seeff LB: Diagnosis, management, and treatment of hepatitis C: an update. Hepatology. 2009, 49 (4): 1335-1374. 10.1002\/hep.22759.","journal-title":"Hepatology"},{"issue":"4","key":"2807_CR2","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1053\/gast.2002.35950","volume":"123","author":"JG McHutchison","year":"2002","unstructured":"McHutchison JG, Manns M, Patel K, Poynard T, Lindsay KL, Trepo C, Dienstag J, Lee WM, Mak C, Garaud JJ, Albrecht JK: Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C. Gastroenterology. 2002, 123 (4): 1061-1069. 10.1053\/gast.2002.35950.","journal-title":"Gastroenterology"},{"issue":"9286","key":"2807_CR3","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/S0140-6736(01)06102-5","volume":"358","author":"MP Manns","year":"2001","unstructured":"Manns MP, McHutchison JG, Gordon SC, Rustgi VK, Shiffman M, Reindollar R, Goodman ZD, Koury K, Ling M, Albrecht JK: Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet. 2001, 358 (9286): 958-965. 10.1016\/S0140-6736(01)06102-5.","journal-title":"Lancet"},{"issue":"25","key":"2807_CR4","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1056\/NEJMoa1012912","volume":"364","author":"IM Jacobson","year":"2011","unstructured":"Jacobson IM, McHutchison JG, Dusheiko G, Di Bisceglie AM, Reddy KR, Bzowej NH, Marcellin P, Muir AJ, Ferenci P, Flisiak R, George J, Rizzetto M, Shouval D, Sola R, Terg RA, Yoshida EM, Adda N, Bengtsson L, Sankoh AJ, Kieffer TL, George S, Kauffman RS, Zeuzem S: Telaprevir for previously untreated chronic hepatitis C virus infection. N Engl J Med. 2011, 364 (25): 2405-2416. 10.1056\/NEJMoa1012912.","journal-title":"N Engl J Med"},{"issue":"13","key":"2807_CR5","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1056\/NEJMoa1010494","volume":"364","author":"F Poordad","year":"2011","unstructured":"Poordad F, McCone J, Bacon BR, Bruno S, Manns MP, Sulkowski MS, Jacobson IM, Reddy KR, Goodman ZD, Boparai N, DiNubile MJ, Sniukiene V, Brass CA, Albrecht JK, Bronowicki JP: Boceprevir for untreated chronic HCV genotype 1 infection. N Engl J Med. 2011, 364 (13): 1195-1206. 10.1056\/NEJMoa1010494.","journal-title":"N Engl J Med"},{"issue":"1","key":"2807_CR6","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0895-4356(96)00268-5","volume":"50","author":"JF Steiner","year":"1997","unstructured":"Steiner JF, Prochazka AV: The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol. 1997, 50 (1): 105-116. 10.1016\/S0895-4356(96)00268-5.","journal-title":"J Clin Epidemiol"},{"key":"2807_CR7","volume-title":"Patient perspectives about the treatment of Hepatitis C (PATH-C)","author":"R Murphy","year":"2011","unstructured":"Murphy R, Shvachko V, Manos M: Patient perspectives about the treatment of Hepatitis C (PATH-C). 2011, San Francisco, CA: Hepatology: American Association for the Study of Liver Diseases"},{"issue":"4","key":"2807_CR8","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1002\/hep.24641","volume":"54","author":"MG Ghany","year":"2011","unstructured":"Ghany MG, Nelson DR, Strader DB, Thomas DL, Seeff LB: An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology. 2011, 54 (4): 1433-1444. 10.1002\/hep.24641.","journal-title":"Hepatology"},{"issue":"3","key":"2807_CR9","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.jhep.2005.04.009","volume":"43","author":"P Ferenci","year":"2005","unstructured":"Ferenci P, Fried MW, Shiffman ML, Smith CI, Marinos G, Goncales FL, Haussinger D, Diago M, Carosi G, Dhumeaux D, Craxi A, Chaneac M, Reddy KR: Predicting sustained virological responses in chronic hepatitis C patients treated with peginterferon alfa-2a (40 KD)\/ribavirin. J Hepatol. 2005, 43 (3): 425-433. 10.1016\/j.jhep.2005.04.009.","journal-title":"J Hepatol"},{"issue":"2","key":"2807_CR10","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1056\/NEJMoa066403","volume":"357","author":"ML Shiffman","year":"2007","unstructured":"Shiffman ML, Suter F, Bacon BR, Nelson D, Harley H, Sola R, Shafran SD, Barange K, Lin A, Soman A, Zeuzem S: Peginterferon alfa-2a and ribavirin for 16 or 24 weeks in HCV genotype 2 or 3. N Engl J Med. 2007, 357 (2): 124-134. 10.1056\/NEJMoa066403.","journal-title":"N Engl J Med"},{"issue":"11","key":"2807_CR11","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1016\/j.cgh.2010.07.012","volume":"8","author":"LA Beste","year":"2010","unstructured":"Beste LA, Ioannou GN, Larson MS, Chapko M, Dominitz JA: Predictors of early treatment discontinuation among patients with genotype 1 hepatitis C and implications for viral eradication. Clin Gastroenterol Hepatol. 2010, 8 (11): 972-978. 10.1016\/j.cgh.2010.07.012.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"9","key":"2807_CR12","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1097\/MEG.0b013e3281bcb8d8","volume":"19","author":"DL Sylvestre","year":"2007","unstructured":"Sylvestre DL, Clements BJ: Adherence to hepatitis C treatment in recovering heroin users maintained on methadone. Eur J Gastroenterol Hepatol. 2007, 19 (9): 741-747. 10.1097\/MEG.0b013e3281bcb8d8.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"4","key":"2807_CR13","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/j.1524-4733.2009.00691.x","volume":"13","author":"D Mitra","year":"2010","unstructured":"Mitra D, Davis KL, Beam C, Medjedovic J, Rustgi V: Treatment patterns and adherence among patients with chronic Hepatitis C virus in a US Managed Care Population. Value Health. 2010, 13 (4): 479-486. 10.1111\/j.1524-4733.2009.00691.x.","journal-title":"Value Health"},{"issue":"2","key":"2807_CR14","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1097\/MCG.0b013e3181ba9992","volume":"44","author":"SK Satapathy","year":"2010","unstructured":"Satapathy SK, Lingisetty CS, Proper S, Chaudhari S, Williams S: Equally poor outcomes to pegylated interferon-based therapy in African Americans and Hispanics with chronic hepatitis C infection. J Clin Gastroenterol. 2010, 44 (2): 140-145. 10.1097\/MCG.0b013e3181ba9992.","journal-title":"J Clin Gastroenterol"},{"key":"2807_CR15","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1747-597X-2-4","volume":"2","author":"MS Huckans","year":"2007","unstructured":"Huckans MS, Loftis JM, Blackwell AD, Linke A, Hauser P: Interferon alpha therapy for hepatitis C: treatment completion and response rates among patients with substance use disorders. Subst Abuse Treat Prev Policy. 2007, 2: 4-10.1186\/1747-597X-2-4.","journal-title":"Subst Abuse Treat Prev Policy"},{"issue":"2","key":"2807_CR16","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/j.1478-3231.2009.02156.x","volume":"30","author":"AA Butt","year":"2010","unstructured":"Butt AA, McGinnis KA, Skanderson M, Justice AC: Hepatitis C treatment completion rates in routine clinical care. Liver Int. 2010, 30 (2): 240-250. 10.1111\/j.1478-3231.2009.02156.x.","journal-title":"Liver Int"},{"issue":"3","key":"2807_CR17","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/j.1365-2710.2008.00912.x","volume":"33","author":"SU Iqbal","year":"2008","unstructured":"Iqbal SU, Cunningham F, Lee A, Miller DR, Li NC, Cheung R, Kazis L: Persistence with hepatitis C therapy in the Department of Veterans Affairs. J Clin Pharm Ther. 2008, 33 (3): 251-261. 10.1111\/j.1365-2710.2008.00912.x.","journal-title":"J Clin Pharm Ther"},{"issue":"6","key":"2807_CR18","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.cgh.2011.03.004","volume":"9","author":"LI Backus","year":"2011","unstructured":"Backus LI, Boothroyd DB, Phillips BR, Belperio P, Halloran J, Mole LA: A sustained virologic response reduces risk of all-cause mortality in patients with hepatitis C. Clin Gastroenterol Hepatol. 2011, 9 (6): 509-516. 10.1016\/j.cgh.2011.03.004. e501","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"2807_CR19","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1086\/600058","volume":"49","author":"M Vogel","year":"2009","unstructured":"Vogel M, Deterding K, Wiegand J, Gruner NH, Baumgarten A, Jung MC, Manns MP, Wedemeyer H, Rockstroh JK: Initial presentation of acute hepatitis C virus (HCV) infection among HIV-negative and HIV-positive individuals-experience from 2 large German networks on the study of acute HCV infection. Clin Infect Dis. 2009, 49 (2): 317-319. author reply 319","journal-title":"Clin Infect Dis"},{"issue":"2","key":"2807_CR20","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/hep.21043","volume":"43","author":"J Wiegand","year":"2006","unstructured":"Wiegand J, Buggisch P, Boecher W, Zeuzem S, Gelbmann CM, Berg T, Kauffmann W, Kallinowski B, Cornberg M, Jaeckel E, Wedemeyer H, Manns MP: Early monotherapy with pegylated interferon alpha-2b for acute hepatitis C infection: the HEP-NET acute-HCV-II study. Hepatology. 2006, 43 (2): 250-256. 10.1002\/hep.21043.","journal-title":"Hepatology"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-0500-7-266.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T22:14:47Z","timestamp":1548195287000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/1756-0500-7-266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,24]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["2807"],"URL":"https:\/\/doi.org\/10.1186\/1756-0500-7-266","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,24]]},"assertion":[{"value":"16 October 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"266"}}